四基因免疫特征预测甲状腺癌去分化与免疫耗竭
本研究利用一个探索队列和两个验证队列,识别出在去分化甲状腺癌(DDTC)中稳定失调的免疫相关基因(IRG),构建了基于四个IRG(PRKCQ、PLAUR、PSMD2、BMP7)的基因特征。该特征对甲状腺癌去分化具有满意的预测价值,并与组织学亚型(P=0.026)、淋巴结转移(P=0.001)和BRAFV600E突变(P<0.001)显著相关。PRKCQ表达下调缩短了甲状腺癌患者的无病生存期。
要点
- 四基因特征(PRKCQ、PLAUR、PSMD2、BMP7)可预测甲状腺癌去分化。
- 该特征与组织学亚型、淋巴结转移及BRAFV600E突变显著相关。
- PRKCQ下调与甲状腺癌患者无病生存期缩短相关。
核心结论
- 免疫相关基因参与甲状腺癌去分化和免疫耗竭过程,是DDTC的潜在生物标志物。
研究设计与样本
- 使用一个探索队列和两个验证队列识别稳定失调的IRG并获取去分化的独立危险因素。
- IRG构成基因特征,通过受试者工作特征曲线检验其预测价值。
- 分析特征与分化相关基因、免疫检查点及预后的相关性,并进行基因集富集分析。
主要发现
- 四个IRG(PRKCQ、PLAUR、PSMD2、BMP7)在DDTC中反复失调,构成的特征对去分化有满意预测价值。
- 免疫检查点与四个IRG及IRG特征密切相关。
- IRG特征与组织学亚型(P=0.026)、淋巴结转移(P=0.001)和BRAFV600E突变(P<0.001)显著相关。
- PRKCQ表达下调缩短甲状腺癌患者无病生存期。
- 识别出若干与IRG特征内在相关的信号通路。
临床怎么用
- 该四基因特征或可作为预测甲状腺癌去分化和免疫耗竭的潜在生物标志物。
- PRKCQ表达下调提示甲状腺癌患者无病生存期可能缩短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The role of immune-related genes (IRGs) in thyroid cancer dedifferentiation and accompanying immune exhaustion remains largely unexplored. OBJECTIVE: To construct a significant IRG-based signature indicative of dedifferentiation and immune exhaustion in thyroid cancer. DESIGN AND SETTINGS: One exploratory cohort and 2 validation cohorts were used to identify stably dysregulated IRGs in dedifferentiated thyroid cancer (DDTC) and to obtain independent risk factors for dedifferentiation. The IRGs formed a gene signature, whose predictive value was tested by the receiver operating characteristic curve. Correlations between the signature and differentiation-related genes, immune checkpoints, and prognosis were analyzed. Gene set enrichment analyses were performed to identify related signaling pathways. RESULTS: Four IRGs (PRKCQ, PLAUR, PSMD2, and BMP7) were found to be repeatedly dysregulated in DDTC, and they formed an IRG-based signature with a satisfactory predictive value for thyroid cancer dedifferentiation. Correlation analyses revealed that immune checkpoints were closely related to the 4 IRGs and the IRG-based signature, which was significantly associated with the histological subtype (P = 0.026), lymph node metastasis (P = 0.001), and BRAFV600E mutation (P < 0.001). The downregulated expression of PRKCQ shortened the disease-free survival for patients with thyroid cancer. Furthermore, we identified several signaling pathways inherently associated with the IRG-based signature. CONCLUSIONS: This study suggests that IRGs participate in the dedifferentiation and immune exhaustion process of thyroid cancer and are potential biomarkers for DDTC.
引用
- Li CW, Shi X, Ma B, et al. A 4 Gene-based Immune Signature Predicts Dedifferentiation and Immune Exhaustion in Thyroid Cancer. J Clin Endocrinol Metab. 2021. PMID: 33656532. doi:10.1210/clinem/dgab132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。